Free Trial

Mirum Pharmaceuticals (MIRM) SEC Filings & 10K Form

Mirum Pharmaceuticals logo
$48.46 -0.52 (-1.06%)
Closing price 06/11/2025 04:00 PM Eastern
Extended Trading
$48.46 0.00 (0.00%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Mirum Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/06/2025
10:59 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
06/02/2025
6:46 PM
Mirum Pharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:30 PM
Mirum Pharmaceuticals (Issuer)
Walbert Timothy P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:33 PM
Fischer Laurent (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:34 PM
Cardon Lon (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:35 PM
Fairey William (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:36 PM
Brege Laura (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:38 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
6:39 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
5:43 PM
Mirum Pharmaceuticals (Subject)
Ramasastry Saira (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2025
3:35 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2025
10:59 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/07/2025
9:57 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
04/14/2025
3:07 PM
Mirum Pharmaceuticals (Filer)
Form DEFA14A
04/14/2025
3:16 PM
Mirum Pharmaceuticals (Filer)
Form ARS
04/14/2025
3:06 PM
Mirum Pharmaceuticals (Filer)
Form DEF 14A
03/19/2025
4:40 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:30 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:30 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:30 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:04 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:51 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:12 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:30 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:28 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
3:43 PM
Mirum Pharmaceuticals (Subject)
Radovich Peter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:49 PM
Mirum Pharmaceuticals (Subject)
Peetz Christopher (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
3:17 PM
Mirum Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/26/2025
3:06 PM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
3:09 PM
Mirum Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
11:01 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/14/2025
11:06 AM
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/14/2025
11:09 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/14/2025
11:11 AM
JANUS HENDERSON GROUP PLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/04/2025
4:30 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:30 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:30 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:48 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:48 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:49 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:50 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump set to Boost Social Security Checks by 400%? (Ad)

If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...

Click here to see the details because the stakes couldn't be any higher.
01/23/2025
4:49 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:51 PM
Mirum Pharmaceuticals (Issuer)
Radovich Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:53 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:55 PM
Mirum Pharmaceuticals (Issuer)
Quan Joanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
4:56 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:21 PM
Mirum Pharmaceuticals (Issuer)
Quan Joanne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
7:32 AM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:38 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
4:34 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:32 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
3:34 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:44 AM
BlackRock, Inc. (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G/A
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G/A
10/01/2024
3:39 PM
GREY MICHAEL G (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:39 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:18 PM
BJERKHOLT ERIC (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:04 PM
Heron Patrick J (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:11 PM
Mirum Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
4:32 PM
Mirum Pharmaceuticals (Issuer)
Peetz Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
12:12 PM
JANUS HENDERSON GROUP PLC (Filed by)
Mirum Pharmaceuticals (Subject)
Form SC 13G
07/03/2024
5:19 PM
Howe Jolanda (Reporting)
Mirum Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
4:35 PM
Longpre Lara (Reporting)
Mirum Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/25/2024
4:15 PM
Mirum Pharmaceuticals (Issuer)
Vig Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
3:31 PM
Mirum Pharmaceuticals (Subject)
Vig Pamela (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
7:03 AM
Mirum Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:MIRM) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners